Skip to content
Home/Companies/Biotech/Allogenica
Allogenica

Allogenica

Biotech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Allogenica?

Allogenica is a French Biotech company, currently owned by Aloe Private Equity since 2022.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
Aloe Private Equity
Investor
Aloe Private Equity
Sorbonne Venture · 2022 · VC

Key facts

HQFrance
SectorBiotech
StatusActive
Websitewww.allogenica.com

More from Sorbonne Venture

Other portfolio companies in the same fund.

DiogenX
Active
BiotechFrance
O-Kidia
Active
Austral DX
Austral DX
Active
MedTechFrance· 2025
EVerZom
Active
BiotechFrance· 2025
Biomemory
Active
TMTFrance· 2024
Polygon
Active
BiotechFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Allogenica?

Allogenica is currently owned by Aloe Private Equity, through Sorbonne Venture, since 2022.

When did Aloe Private Equity acquire Allogenica?

Aloe Private Equity acquired Allogenica in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue